EA200001208A1 - Противовирусные соединения - Google Patents
Противовирусные соединенияInfo
- Publication number
- EA200001208A1 EA200001208A1 EA200001208A EA200001208A EA200001208A1 EA 200001208 A1 EA200001208 A1 EA 200001208A1 EA 200001208 A EA200001208 A EA 200001208A EA 200001208 A EA200001208 A EA 200001208A EA 200001208 A1 EA200001208 A1 EA 200001208A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- alkyl
- hydrogen
- halogen
- virus
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000002155 anti-virotic effect Effects 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 229910052736 halogen Inorganic materials 0.000 abstract 4
- 150000002367 halogens Chemical group 0.000 abstract 4
- 150000002431 hydrogen Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000004076 pyridyl group Chemical group 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- -1 (C-C) -alkyl Chemical group 0.000 abstract 1
- 241000710190 Cardiovirus Species 0.000 abstract 1
- 241001466953 Echovirus Species 0.000 abstract 1
- 241000709661 Enterovirus Species 0.000 abstract 1
- 241000991587 Enterovirus C Species 0.000 abstract 1
- 241000711549 Hepacivirus C Species 0.000 abstract 1
- 241000710185 Mengo virus Species 0.000 abstract 1
- 241000709664 Picornaviridae Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/010299 WO1999059587A1 (en) | 1998-05-20 | 1998-05-20 | Anti-viral compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200001208A1 true EA200001208A1 (ru) | 2001-06-25 |
Family
ID=22267098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200001208A EA200001208A1 (ru) | 1998-05-20 | 1998-05-20 | Противовирусные соединения |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1077701A4 (cs) |
| JP (1) | JP2002515433A (cs) |
| KR (1) | KR20010025055A (cs) |
| CN (1) | CN1292697A (cs) |
| AU (1) | AU7583098A (cs) |
| BR (1) | BR9815899A (cs) |
| CA (1) | CA2332403A1 (cs) |
| CZ (1) | CZ289425B6 (cs) |
| EA (1) | EA200001208A1 (cs) |
| HU (1) | HUP0102117A2 (cs) |
| IL (1) | IL139166A0 (cs) |
| NO (1) | NO20005795L (cs) |
| SK (1) | SK17482000A3 (cs) |
| TR (1) | TR200003414T2 (cs) |
| WO (1) | WO1999059587A1 (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR213700A0 (en) | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
| AR048650A1 (es) * | 2004-05-04 | 2006-05-10 | Tibotec Pharm Ltd | Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih |
| DE602005020313D1 (de) | 2004-08-12 | 2010-05-12 | Amgen Inc | Bisaryl-sulfonamide |
| US7666880B2 (en) | 2005-03-21 | 2010-02-23 | S*Bio Pte Ltd. | Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications |
| MY147647A (en) * | 2005-03-21 | 2012-12-31 | S Bio Pte Ltd | Imidazo [1,2-a] pyridine derivatives : preparation and pharmaceutical applications |
| CA2633760A1 (en) | 2005-12-21 | 2007-07-05 | Abbott Laboratories | Anti-viral compounds |
| ES2395386T3 (es) | 2005-12-21 | 2013-02-12 | Abbott Laboratories | Compuestos antivirales |
| ES2378473T3 (es) | 2005-12-21 | 2012-04-12 | Abbott Laboratories | Compuestos antivirales |
| WO2008133753A2 (en) | 2006-12-20 | 2008-11-06 | Abbott Laboratories | Anti-viral compounds |
| NZ590286A (en) * | 2008-05-27 | 2011-08-26 | Biota Scient Management | Phosphate and sulphate salts of 6-{ 2-[1-(6-methyl-3-pyrazinyl)-4-piperidinyl]ethoxy} -3-ethoxy-1,2-benzisoxazole |
| WO2010075380A1 (en) | 2008-12-23 | 2010-07-01 | Abbott Laboratories | Anti-viral compounds |
| CA2740193A1 (en) | 2008-12-23 | 2010-07-01 | Abbott Laboratories | Anti-viral compounds |
| EP2419404B1 (en) | 2009-04-15 | 2015-11-04 | AbbVie Inc. | Anti-viral compounds |
| WO2014060381A1 (de) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Heterocyclische verbindungen als schädlingsbekämpfungsmittel |
| CN104884449A (zh) | 2012-10-31 | 2015-09-02 | 拜尔农作物科学股份公司 | 作为害虫防治剂的新的杂环化合物 |
| CN104370732B (zh) * | 2014-01-26 | 2015-08-19 | 山东信立泰药业有限公司 | 一种氯吡格雷及其中间体的制备方法 |
| CN109535405B (zh) * | 2017-09-21 | 2021-07-30 | 宁波聚嘉新材料科技有限公司 | 一种基于2-(4-羧基苯基)-5-羟基吡啶并咪唑的聚芳酯的制备方法 |
| CN109810085B (zh) * | 2019-04-19 | 2019-07-19 | 上海皓元生物医药科技有限公司 | Acc抑制剂及其中间体的制备方法 |
| CN110746450A (zh) * | 2019-09-17 | 2020-02-04 | 济南康和医药科技有限公司 | 一种贝前列素钠关键中间体的合成方法 |
| CN117902992A (zh) * | 2024-01-04 | 2024-04-19 | 浙江永太科技股份有限公司 | 一种2,4-二氟苯基甘氨酸的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4096264A (en) * | 1975-12-09 | 1978-06-20 | Merck & Co., Inc. | Certain substituted imidazo [1,2-a] pyridines |
| US4250174A (en) * | 1979-05-02 | 1981-02-10 | Merck & Co., Inc. | 3-Substituted imidazo [1,2-A] pyridines |
| US5693661A (en) * | 1995-06-07 | 1997-12-02 | Eli Lilly And Company | Anti-viral compounds |
| EA001316B1 (ru) * | 1996-06-05 | 2001-02-26 | Эли Лилли Энд Компании | Соединения, обладающие антивирусной активностью |
| US5891874A (en) * | 1996-06-05 | 1999-04-06 | Eli Lilly And Company | Anti-viral compound |
| US5821242A (en) * | 1996-06-06 | 1998-10-13 | Eli Lilly And Company | Anti-viral compounds |
-
1998
- 1998-05-20 CZ CZ20004278A patent/CZ289425B6/cs unknown
- 1998-05-20 TR TR2000/03414T patent/TR200003414T2/xx unknown
- 1998-05-20 CA CA002332403A patent/CA2332403A1/en not_active Abandoned
- 1998-05-20 EA EA200001208A patent/EA200001208A1/ru unknown
- 1998-05-20 IL IL13916698A patent/IL139166A0/xx unknown
- 1998-05-20 AU AU75830/98A patent/AU7583098A/en not_active Abandoned
- 1998-05-20 WO PCT/US1998/010299 patent/WO1999059587A1/en not_active Application Discontinuation
- 1998-05-20 HU HU0102117A patent/HUP0102117A2/hu unknown
- 1998-05-20 SK SK1748-2000A patent/SK17482000A3/sk unknown
- 1998-05-20 KR KR1020007012999A patent/KR20010025055A/ko not_active Withdrawn
- 1998-05-20 CN CN988140519A patent/CN1292697A/zh active Pending
- 1998-05-20 BR BR9815899-6A patent/BR9815899A/pt not_active IP Right Cessation
- 1998-05-20 JP JP2000549252A patent/JP2002515433A/ja not_active Withdrawn
- 1998-05-20 EP EP98923565A patent/EP1077701A4/en not_active Withdrawn
-
2000
- 2000-11-16 NO NO20005795A patent/NO20005795L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1077701A1 (en) | 2001-02-28 |
| HUP0102117A2 (hu) | 2001-12-28 |
| NO20005795D0 (no) | 2000-11-16 |
| CA2332403A1 (en) | 1999-11-25 |
| CZ20004278A3 (en) | 2001-05-16 |
| CN1292697A (zh) | 2001-04-25 |
| KR20010025055A (ko) | 2001-03-26 |
| SK17482000A3 (sk) | 2005-03-04 |
| NO20005795L (no) | 2001-01-18 |
| TR200003414T2 (tr) | 2001-03-21 |
| WO1999059587A1 (en) | 1999-11-25 |
| AU7583098A (en) | 1999-12-06 |
| CZ289425B6 (cs) | 2002-01-16 |
| JP2002515433A (ja) | 2002-05-28 |
| EP1077701A4 (en) | 2002-03-20 |
| BR9815899A (pt) | 2001-02-20 |
| IL139166A0 (en) | 2001-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200001208A1 (ru) | Противовирусные соединения | |
| EA200100955A1 (ru) | 4-ОКСО-4,7-ДИГИДРОТИЕНО [2,3-b]ПИРИДИН-5-КАРБОКСАМИДЫ В КАЧЕСТВЕ АНТИВИРУСНЫХ СРЕДСТВ | |
| EA200500610A1 (ru) | Композиция для лечения инфекции, вызываемой вирусами семейств flaviviridae | |
| ATE414520T1 (de) | 3 oder 2 hydroxymethyl substituierte nucleoside derivate und ihre verwendung zur behandlung von virusinfektionen | |
| EA200500723A1 (ru) | Соединения бензофурана, композиции и способы лечения и профилактики инфекций, вызванных вирусом гепатита c, и связанных с ним заболеваний | |
| ATE270103T1 (de) | Aminophenoxyessigsäure derivate als neuroschützende mittel | |
| IS8448A (is) | Lifrarbólgu C-veirutálmar | |
| EA199900936A1 (ru) | Фунгицидные трифторметилалкиламинотриазолопиримидины | |
| EA200100983A1 (ru) | Производные 13-метилэритромицина | |
| EA200300023A1 (ru) | 3'-ПРОЛЕКАРСТВА 2'-ДЕЗОКСИ-β-L-НУКЛЕОЗИДОВ | |
| BR9815166A (pt) | "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral" | |
| EA200600582A1 (ru) | Способы и композиции для лечения вирусного гепатита с | |
| DE60001218D1 (de) | [1,8]-naphthyridinderivate derivate mit antiviraler wirkung | |
| NO179975C (no) | Analogifremgangsmåte for fremstilling av heterocykliske derivater | |
| EP0914130A4 (en) | NEW ANTIVIRAL COMPOSITIONS | |
| JP2003511415A5 (cs) | ||
| EA199901016A1 (ru) | 9-оксим-производные эритромицина | |
| NO20004978L (no) | Semi-syntetiske ecteinascidiner | |
| EA200001133A1 (ru) | Антипикорнавирусные композиции, их получение и применение | |
| EA200200625A1 (ru) | Антипикорнавирусные соединения и композиции, их фармацевтическое применение и вещества для их синтеза | |
| EA199800661A1 (ru) | Ингибиторы аспартильных протеаз | |
| NO20013085L (no) | Fosfororganiske forbindelser og deres anvendelse | |
| EA199800019A1 (ru) | Способ повышения плотности кальциевых каналов | |
| EA199801078A1 (ru) | Соединения, обладающие антивирусной активностью | |
| EA200101103A1 (ru) | НОВЫЕ 15-ЧЛЕННЫЕ 8а- И 9а ЛАКТАМЫ |